Last Updated on October 17, 2024 by The Health Master
Caplin Steriles, a subsidiary company of Caplin Point Laboratories, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA).
Also read more about Caplin Steriles, click here
This ANDA is for Neostigmine Methylsulfate Injection USP, 5 mg/10 mL (0.5 mg/mL) and 10 mg/10 mL (1 mg/mL), Multiple-Dose vial presentations, a generic therapeutic equivalent version of (RLD), BLOXIVERZ Injection, of Exela Pharma Sciences, LLC.
Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolarising neuromuscular blocking agents (NMBAs) after surgery.
According to IQVIA (IMS Health), Neostigmine Methylsulfate Injection had US sales data of approximately $20 million for the 12-month period ending Dec 2020.
Also read:
Gilead gets USFDA nod to treat metastatic urothelial cancer
NATCO gets tentative USFDA nod for Ibrutinib tablets
First AI device to help detect colon cancer gets USFDA nod
Aleor gets tentative USFDA nod for drug for topical treatment
Zydus Cadila gets final USFDA nod for drug to treat High…
Dr Reddy’s launch generic Sapropterin Dihydrochloride Powder for Oral Solution in…
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
